Cite
ATPIF1 inactivation promotes antitumor immunity through metabolic reprogramming of CD8+ T cells
MLA
Shuang Shen, et al. ATPIF1 Inactivation Promotes Antitumor Immunity through Metabolic Reprogramming of CD8+ T Cells. Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ab1f05c571247d60436ab36d594ed352&authtype=sso&custid=ns315887.
APA
Shuang Shen, Yichun Wang, Ming Shi, Yaya Guan, Hui Wang, Genshen Zhong, Minna Wu, Yunwei Lou, Ying Wang, Jianping Ye, Yuan Li, Xiaoying Zhang, Xinyu Cao, Jiaojiao Zhang, Zhongxin Zhang, & Yinming Liang. (2020). ATPIF1 inactivation promotes antitumor immunity through metabolic reprogramming of CD8+ T cells.
Chicago
Shuang Shen, Yichun Wang, Ming Shi, Yaya Guan, Hui Wang, Genshen Zhong, Minna Wu, et al. 2020. “ATPIF1 Inactivation Promotes Antitumor Immunity through Metabolic Reprogramming of CD8+ T Cells,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ab1f05c571247d60436ab36d594ed352&authtype=sso&custid=ns315887.